The global pneumatic nebulizers market size is anticipated to reach USD 1.05 billion by 2028, registering a CAGR of 6.1% over the forecast period. Nebulizers are a medical device which is used for producing and converting the drug into mist and delivers directly to the lungs. The method of nebulization is commonly used for the treatment of respiratory diseases like asthma, cystic fibrosis and COPD. There are various devices available for nebulization, and some are rechargeable and electrically powered.
The increasing incidence of chronic respiratory diseases, demand for home healthcare devices, and growing geriatric population are the factors expected to drive the market. According to statistics published by the CDC, approximately 18.4 million adults in the U.S. suffer from asthma. Easy availability of portable and compact pneumatic nebulizers is ideal for home use, scientific innovations in these devices reduces the noise created by them & improve their functionality and these factors are increasing their adoption in-home healthcare. Furthermore, these devices are favored by third-party payers like insurance companies, who aim to reduce costs while providing quality healthcare services.
According to Minnesota Health Dept, using nebulizer lowers infection risk as compared to other aerosol producing procedures. Moreover, according to ISAM, aerosols are the nebulizer which doesn’t carry viral particles from the patient because they are generated from the fluid inside the nebulized chamber. According to International Agency for Research on Cancer, total number of new lung cancer occurred in year 2020 was 2,206,771. This high incidence of lung cancer is further increasing the demand for nebulizers.
The Global Nebulizer Market is segmented by type, portability, sales channel, end use and region. On the basis of type, it is categorized into Pneumatic Nebulizer, Ultrasonic Nebulizer and Mesh Nebulizer. By Portability, it is categorized into Tabletop Nebulizer and Portable Nebulizer. Further, by Sales Channel, it is categorized into Direct Purchase and Online Purchase. End user covers hospitals, clinics, and home healthcare. Moreover, on the basis of region, it is categorized into North America, Europe, Asia-Pacific, Middle East and Africa and Latin America.
The global prominent players which are dominant in the pneumatic nebulizers market include Koninklijke Philips N.V., Omron Corp., PARI Pharma, General Electric Company, Allied Healthcare Products, Inc., BD (Becton, Dickinson & Company), GF Health Products, Inc., Medline Industries, Inc., Briggs Healthcare and Vectura Group Plc, among others.
Segmentation and Scope of the Global Pneumatic Nebulizers Market
Global Pneumatic Nebulizers market is segmented into type, portability, sales channel, end use and region.